- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05486442
ACT for Weight-related Experiential Avoidance
August 2, 2022 updated by: Buse Keskindag, Bahcesehir Cyprus University
Acceptance and Commitment Training for Weight-related Experiential Avoidance
This study aimed to investigate whether Acceptance and Commitment Therapy/Training would be helpful to reduce weight-related experiential avoidance among individuals who reported weight concern
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This quasi-experimental study aimed to examine the efficacy of Acceptance and Commitment Therapy/Training (ACT) in reducing weight-related experiential avoidance.
Data were collected with a convenience sampling technique.
After obtaining ethical approval, participants were invited to participate in the study via advertisements, and online posts.
Due to the small sample size, participants who were willing to attend group discussions were included in the experimental group.
Participants in the control group did not receive manipulation.
All participants were provided with an informed consent form.
All participants completed a questionnaire measuring outcomes (weight-related experiential avoidance, general experiential avoidance, eating attitudes, and social physique anxiety) at pre-test, post-test, and follow-up.
Participants in the experimental group received ACT training including 6 sessions.
The protocol was adapted from Pearson et al. (2012) with their permission.
Each session took approximately 80 mins.
Several aspects of ACT approach were discussed in the sessions.
In session one, ACT approach was introduced.
In session two, creative hopelessness was discussed.
In session three, control strategies related to weight concern were identified.
In session four, mindfulness exercises were completed.
In the fifth session, values for meaningful life experience were discussed.
In the last, sixth session, the ways to commit to action were discussed.
Each session included exercises and homework.
At the end of the study, the participants were provided with debrief form.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nicosia, Cyprus
- Near East University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals who were 18 years and older
- Ability to read and understand Turkish
Exclusion Criteria:
- Individuals who have received mental health intervention over the last one year
- and those who were diagnosed with an eating disorder were excluded from the analyses
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
Participants in the experimental group received ACT training in the group setting aiming to reduce weight-related experiential avoidance.
This included 6 sessions in total.
Each session was completed approximately in 80 mins.
|
Participants in the experimental group received weight concern-related ACT training in a group setting.
Each session focused on different dimensions of ACT and included relevant exercises and homeworks.
Dimensions studied included creative hopelessness, control strategies, mindfulness exercises, values and barries to values and commitment to action.
|
|
No Intervention: Control group
Participants in the control group did not receive any manipulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in weight-related experiential avoidance
Time Frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
It was measured by Acceptance and Action Questionnaire for Weight-Related Difficulties-Revised.
The scale includes 10 items that are rated on 7 points scale (1 = not true at all - 7 = completely true).
Higher scores indicate greater weight related experiential avoidance.
|
At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in eating attitudes
Time Frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
Eating attitudes were measured by The Eating Attitudes Test-26.
It includes 26 items that are rated on 4 point scale ('3 = Always, 2 = Usually, 1 = Often, 0 = Sometimes, Rarely, and Never').
The last item (26) requires reverse coding.
Scores 20 and above indicate dysfunctional eating attitudes.
|
At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
|
Change in general experiential avoidance
Time Frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
It was measured by Acceptance and Action Questionnaire-II.
It includes 7 items that are rated on 7 point scale (1 = never true - 7 = always true).
Minimum and maximum scores range between 7 and 49 points.
Higher scores indicate greater general experiential avoidance (psychological inflexibility).
|
At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
|
Change in social physique anxiety
Time Frame: At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
It was measured by The Social Physique Anxiety Scale.
The scale includes 12 items are rated on a 5-point scale (1=not at all true to 5=extremely true).
Higher scores indicate a higher level of anxiety related to the social physique.
Only item 1, 2, 5, 8 and 11 requires reverse coding.
|
At three time points (pre-intervention [baseline], immediately after the intervention, and at three weeks after the intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Meryem Karaaziz, PhD, Near East University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Pearson, Adria N., Victoria M. Follette, and Steven C. Hayes.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 4, 2022
Primary Completion (Actual)
June 3, 2022
Study Completion (Actual)
June 3, 2022
Study Registration Dates
First Submitted
July 30, 2022
First Submitted That Met QC Criteria
August 2, 2022
First Posted (Actual)
August 3, 2022
Study Record Updates
Last Update Posted (Actual)
August 3, 2022
Last Update Submitted That Met QC Criteria
August 2, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- NEU/SS/2022/1208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Behavior
-
McGill UniversityCompleted
-
McGill UniversityCompleted
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Dursun Alper YILMAZCompletedEating Behaviors | Adolescent Nutrition | Nutritional Inequalities | Eating AttitudesTurkey (Türkiye)
-
Kinnaird College for WomenCompletedDisordered Eating Behaviors | Body Image DisturbancePakistan
-
University of LiverpoolCompletedFood Selection | Eating Behavior | Healthy EatingUnited Kingdom
-
University of LiverpoolUniversity of Bristol; Liverpool John Moores University; Economic and Social...CompletedFood Selection | Eating Behavior | Healthy EatingUnited Kingdom
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingEating BehaviorUnited States
-
Pennington Biomedical Research CenterRecruiting
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
Clinical Trials on ACT for weight-related experiential avoidance
-
Hodge, Kenneth M., M.D.TAP Pharmaceutical Products Inc.Unknown